Biosimilars
Biotech
Regulatory
Amgen and Allergan’s Mvasi (bevacizumab, biosimilar) + Combination Therapy Receives
Shots: The approval is based on P-III study results assessing Mvasi vs bevacizumab in patients with non-squamous NSCLC The study demonstrated in biosimilarity of Mvasi with bevacizumab in terms of […]readmore